DPP4 and type 2 diabetes mellitus: This multinational cohort study examines the association of second-line treatment (sulfonylureas, dipeptidyl peptidase 4 inhibitors [DPP-4], or thiazolidinediones) for type 2 diabetes after initial therapy with metformin with hemoglobin A1c (HbA1c) levels.